Will COX-2 + Biomarker = Success? Novartis Tests the Frontiers of Companion Diagnostics
A new genetic blood test that identifies patients at risk of liver toxicities may give Joicela (formerly Prexige) new life.
A new genetic blood test that identifies patients at risk of liver toxicities may give Joicela (formerly Prexige) new life.